Federated Hermes
BIIB icon

Federated Hermes’s Biogen BIIB Stock Holding History

Federated Hermes’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,000
Closed -$2.73M – 2126
2017
Q1 		$2.73M Sell
10,000
-4,000
-29% -$1.13M 0.01% 772
2016
Q4 		$4.03M Buy
+14,000
New +$4.15M 0.01% 618

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes's BIIB Position: Q1 2026 in Review

Federated Hermes reduced its Biogen (BIIB) stake by 26% in Q1 2026, selling an estimated $6.24M and leaving 97,279 shares worth $17.8M. The position accounts for 0.03% of the portfolio, ranked #498.

Federated Hermes first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $187M in Q1 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Federated Hermes held 97,279 shares of Biogen worth $17.8M as of Q1 2026.
  • Federated Hermes sold 33,889 Biogen shares in Q1 2026, an estimated $6.24M.
  • Biogen made up 0.03% of Federated Hermes's portfolio in Q1 2026, its #498 holding.
  • Federated Hermes first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Biogen position peaked at $187M in Q1 2015.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.